Status
Conditions
Study type
Funder types
Identifiers
About
This non-interventional clinical study will be conducted to prospectively collect serial plasma samples from subjects with chronic HBV infection who are initiating antiviral therapy. These samples will be used to estimate clinical utility endpoints for the Aptima HBV Quant assay, which is used as an aid in the management of HBV-infected patients undergoing HBV antiviral therapy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Subject is in one of the following patient populations:
Underlying liver disease other than HBV
Receiving chemotherapy, immunosuppressive agents
Subject is unsuitable for study participation based on the Investigator's decision (eg, unlikely to comply with study visit schedule, significant medical complication)
Participating in another investigational study that the Investigator believes might interfere with the subject's participation in this study
331 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal